Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP1 | P07148 | 1/20 | 0.49 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.35 |
| ▸ | INPP5B | P32019 | 1/20 | 0.35 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | F10 | P00742 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL6810793 | 0.98 | FABP1 (0.47) | FABP1SLC22A6INPPL1INPP5BINPP5A | |
| SCHEMBL1890372 | 0.87 | FABP1 (0.41) | FABP1SLC22A6CA1CA2CA9 | |
| SCHEMBL17466328 | 0.87 | FABP1 (0.41) | FABP1SLC22A6 | |
| SCHEMBL8822555 | 0.86 | FABP1 (0.40) | FABP1SLC22A6INPPL1INPP5BINPP5A | |
| SCHEMBL14015373 | 0.85 | CA2 (0.45) | FABP1CA5ACA1CA2CA9 | |
| SCHEMBL514247 | 0.82 | SLC22A6 (0.53) | FABP1SLC22A6CA5AELANECA1 | |
| SCHEMBL6747882 | 0.82 | FABP1 (0.63) | FABP1SLC22A6CA5AMETAP2METAP1 | |
| SCHEMBL10647420 | 0.81 | SLC22A6 (0.53) | FABP1SLC22A6CA5AELANESMN1; SMN2 | |
| SCHEMBL1882763 | 0.80 | SLC22A6 (0.52) | FABP1SLC22A6CA5AELANECA1 | |
| Ammonia Solution, Strong SCHEMBL1278643 | 0.80 | SLC22A6 (0.52) | FABP1SLC22A6CA5AELANECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023058368-A1 | METHOD FOR PRODUCING GLASS SUBSTRATE, PRETREATMENT METHOD FOR GLASS SUBSTRATE, AND METHOD FOR PRODUCING MULTILAYER BODY COMPRISING GLASS SUBSTRATE | 日産化学株式会社 | 2023-04-13 | — | — | WO | disclosed |
| WO-2023013727-A1 | RIBBED SUBSTRATE AND OPTICAL SEMICONDUCTOR DEVICE | 株式会社カネカ | 2023-02-09 | — | — | WO | disclosed |
| WO-2022210799-A1 | SUBSTRATE STACK, IMAGE SENSOR, AND METHOD FOR MANUFACTURING SUBSTRATE STACK | 株式会社カネカ | 2022-10-06 | — | — | WO | disclosed |
| WO-2022210798-A1 | OPTICAL SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING SAME, SOLID-STATE IMAGING DEVICE, AND ELECTRONIC APPARATUS | 株式会社カネカ | 2022-10-06 | — | — | WO | disclosed |
| CN-106024592-B | Silicon-based interlayer composition and related methods | 台湾积体电路制造股份有限公司 | 2019-07-12 | — | — | CN | disclosed |
| CN-106024592-A | Silicon-based interlayer composition and related methods | 台湾积体电路制造股份有限公司 | 2016-10-12 | — | — | CN | disclosed |
| US-20160027592-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2016-01-28 | — | — | US | disclosed |
| US-8795942-B2 | Positive resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2014-08-05 | — | — | US | disclosed |
| US-20090252932-A1 | ACTINIC ENERGY RAY CURABLE RESION COMPOSITION AND USE THEREOF | KURARAY CO., LTD. (JP) | 2009-10-08 | — | — | US | disclosed |
| EP-1449833-B1 | BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION | WAKO PURE CHEM IND LTD (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-20080153030-A1 | Positive resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| US-7374857-B2 | Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition | WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) | 2008-05-20 | — | — | US | disclosed |
| US-20070189671-A1 | Method for manufacturing optical waveguide chip | SR CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| CN-1238766-C | Positive type radiation-sensitive composition and method for forming pattern | JSR CORP (JP) | 2006-01-25 | — | — | CN | disclosed |
| US-20050038261-A1 | Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition | WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) | 2005-02-17 | — | — | US | disclosed |
| EP-1449833-A1 | BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION | Wako Pure Chemical Industries, Ltd. (JP) | 2004-08-25 | — | — | EP | disclosed |
| CN-1507580-A | Positive type radiation-sensitive composition and method for forming pattern | JSR株式会社 | 2004-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038261-A1 | Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition | ASIC1, GAR1, RER1 | FABP1 4396/4885SLC22A6 4163/4885INPPL1 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.